Delivery Order SPE2DB25D3008-SPE2DB25FRBDN

The Defense Logistics Agency awarded a $1,669 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562191408 EMGALITY 120 MG/ML PENML. The contract has a period of performance from September 15 through September 18, 2023, with all work to be conducted by the prime contractor in Conshohocken, Pennsylvania. Emgality is a medication used to prevent migraines, and this delivery order will supply the drug to support the Department of Defense's health programs....

This delivery order was awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp on October 18, 2023 for $2,233.29. The order is for EMGALITY 120 MG/ML PENML to be delivered by October 19, 2023 under a firm fixed price contract. The place of performance is Conshohocken, Pennsylvania. No set-aside designation was used for this order, which will be fulfilled by Amerisourcebergen Drug Corp's Corporate Office. The Defense Logistics Agency Troop Support Medical...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,729.00, is for the supply of EMGALITY 120 MG/ML PENML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of December 2, 2024. This delivery order is a part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...

This federal contract award, with ID SPE2DB22D3016|SPE2DB25FAEF7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EMGALITY 120 MG/ML PENML, a pharmaceutical product, with a ceiling value of $16,022.52 and a completion date of November 22, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation...

The Defense Logistics Agency awarded a $417 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. As the prime contractor, Amerisourcebergen will deliver the pen injectors to its place of performance in Conshohocken, Pennsylvania by September 22, 2023 under the terms of this order. Emgality is used to treat conditions such as migraine and cluster headaches. The Defense Logistics Agency leverages contracts such as this to efficiently procure...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EMGALITY 120 MG/ML PENML pharmaceutical products. The order has a potential value of $1,018.15 and a completion date of January 19, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a prime contractor that has received multiple federal contracts from DLA Troop...

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product, and has a ceiling value of $1,064.68. The contract is a firm fixed-price delivery order, with a period of performance through February 19, 2025. This contract award is not associated with a set-aside program. Amerisourcebergen...

The Defense Logistics Agency awarded a $2,289.05 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 mg/ml Emgality pens. The prime contractor will deliver the pharmaceutical product to a location in Conshohocken, Pennsylvania by August 22, 2023 under the terms of the order. Emgality is a monoclonal antibody used to treat migraine headaches. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to ensure medical...

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of EMGALITY 120 MG/ML PENML, a prescription medication. The firm-fixed-price contract has a ceiling value of $1,002.72 and a period of performance through August 8, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal...

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of EMGALITY 120 MG/ML PENML medication. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) with a ceiling value of $1,671.20 and an ultimate completion date of August 9, 2024. The award does not have a set-aside designation. Amerisourcebergen, through its corporate office division, will provide the medication to...